RSS

Sixth Element Capital

Newly formed drug discovery company, Azeria Therapeutics, has announced that it has successfully raised £4 million in a Series A investment round from the £70 million CRT Pioneer Fund, managed by Sixth Element Capital. more

News

UK based fund manager, Sixth Element Capital, has announced a £3 million investment in a spin out company from PhoreMost — NeoPhore. more

News